Pat N. Confalone

Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson.

Dialectic Therapeutics, Inc. operates as a pre-clinical biotechnology company. It develops anti-cancer drugs. The company was founded by David G. Genecov and John D. Harkey Jr. in 2018 and is headquartered in Dallas, TX.

Part of Cracken, Harkey & Co. LLC, Consolidated Restaurants Cos., Inc. is a company that operates restaurants. The company is based in Dallas, TX. John D. Harkey has been the CEO of the company since 1998.

United Development Funding III LP engages in the provision of real estate financing services. It intends to originate, acquire, service, and otherwise manage, either alone or in association with others, a portfolio of mortgage loans that are secured by real property or equity interests that hold real property already subject to other mortgages and to issue or acquire an interest in credit enhancements for the benefit of borrowers. The company was founded by Hollis M. Greenlaw in 2003 and is headquartered in Grapevine, TX.

CRO-Nahita Development, Inc. operates restaurants. The company was founded in 2016 and is headquartered in Dallas, TX.

JDH Investment Management LLC provides investment opportunities to the biotech, gene-therapy, non-opiate pain and pharma/therapeutic industries. The company was founded by John D. Harkey is headquartered in Dallas, TX.

Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX.

Durvet, Inc. manufactures and distributes animal health and agriculture products. It offers products for pets, including dogs and cats, equine, and livestock, which include cattle, goats, poultry, sheep, and swine. The firm offers aloe crèmes, shampoos, tail scrubs, skin protectors, cleansers, conditioners, grooming packs, clinging hydrogels, lip shimmers, body washes, and grain treats for horses, ponies, and mules; pastes to remove worms and bots, and insecticides to kill ticks, ants, booklice, carpet beetles, centipedes, cockroaches, confused flour beetles, crickets, earwigs, firebrats, flies, fruit flies, gnats, grasshoppers, hornets, and house flies. The company was founded by James D. Bradley in 1970 and is headquartered in Blue Springs, MO.

The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX.

State Fair of Texas operates a trade fair. The private company is based in Dallas, TX.

Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA.

Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ.

Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million.

Fox & Hound Restaurant Group owns and operates entertainment restaurants. The company was founded 1997 and is headquartered in Dallas, TX.

SSL Holdings, Inc.'s principal activities are designing, manufacturing, and integrating the reliable communication satellites and satellite systems for an international roster of commercial and government customers across the world. SS/L operates as a subsidiary of Loral Space & Communications with the interest in providing of commercial satellites and works with satellite operators to provide spacecraft for a broad range of services including television and radio distribution, digital audio radio, broadband Internet, and mobile communications. Its satellites and subsystem products provide satellite services including direct-to-home television, digital audio radio, broadband internet, mobile satellite services and digital multimedia broadcasting. The company was founded in November 15, 2010 and is headquartered in Palo Alto, California.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada.

Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.

Cracken, Harkey & Co. LLC (Cracken, Harkey, & Co.) is a private equity firm founded in 1997 by John R.W. Cracken and John D. Harkey Jr. The firm is headquartered in Dallas, Texas.

Consolidated Restaurant Operations, Inc. engages in restaurant operations. Its brands include Black Oak Grill, The El Chico, Good Eats, Cantina Laredo, Lucky's Cafe, Silver Fox Steakhouse, III Forks Steakhouse, and Cool River Cafe. The company was founded by Ernest Gene Street, John R. W. Cracken, Stephen P. Harnett and John D. Harkey, Jr. in 1998 and is headquartered in Dallas, TX.

Maxar Space LLC designs and manufactures weather and communications satellites, subsystems and payloads. The firm's services includes television and radio distribution, digital audio radio, broadband Internet, and mobile communications. The company was founded in 1957 and is headquartered in Palo Alto, CA.

LE GP LLC provides natural gas pipeline transportation and transmission services. The private company is based in Dallas, TX. The CEOs of the company are Marshall S. McCrea, Thomas E. Long.